Efficient Ligand efficient E Ef Eff Effi BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 () 2 10 1 0 0 0 1
Fragments Fragments fragments F Fr Fra Frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 1 1 0 0 0 1
Arron Aatkar, arron A Ar Arr Arro BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ,,.,,-, 7 10 1 0 0 0 1
Craig D. craig C Cr Cra Crai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .,,,-,, 7 9 1 0 0 0 1
Nicholas C. nicholas N Ni Nic Nich BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 ..,*.* 6 5 1 0 0 0 1
Cite This: cite C Ci Cit Cite BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 :..,,- 6 10 1 0 0 0 1
Read Online read R Re Rea Read BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 2 1 0 0 0 1
ACCESS ACCESS access A AC ACC ACCE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
Metrics & metrics M Me Met Metr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 no 0 6 1 0 0 0 1
Article Recommendations article A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 1 * 1 10 1 0 0 0 1
ABSTRACT: Sulfur(VI) abstract: A AB ABS ABST BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :()()"-" 8 8 1 0 0 0 1
inhibitors and inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ., 2 9 1 0 0 0 1
they deliver they t th the they BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 1 0 0 0 1
this, libraries this, t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 , 1 9 1 0 0 0 1
leveraging a leveraging l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ., 2 9 1 0 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .-,-- 5 9 1 0 0 0 1
was taken was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 1 0 0 0 1
the site(s) the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (),,. 5 10 1 0 0 0 1
molecular understanding molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 1 0 0 0 1
used for used u us use used BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 "-". 4 5 1 0 0 0 1
■ INTRODUCTION ■ ■ ■ ■ ■ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 4 no 0 10 0 0 0 0 1
The impact the T Th The The BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 8 1 0 0 0 1
spurred interest spurred s sp spu spur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 7 1 0 0 0 1
"beyond-cysteine" approaches "beyond-cysteine" " "b "be "bey BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 "-" 3 9 1 0 0 0 1
residues and residues r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
(Figure 1a). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ().-()() 8 8 1 0 0 0 1
useful electrophiles useful u us use usef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 1 0 0 0 1
nucleophilic amino nucleophilic n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,,, 3 9 1 0 0 0 1
and serine. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 9 1 0 0 0 1
protein pockets protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
development of development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .-,- 4 9 1 0 0 0 1
modulators have modulators m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 , 1 8 1 0 0 0 1
modification of modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 9 1 0 0 0 1
Examples include examples E Ex Exa Exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 ""-- 4 8 1 0 0 0 1
ing, 17 ing, i in ing ing, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,-- 3 9 1 0 0 0 1
coupled receptors coupled c co cou coup BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 7 1 0 0 0 1
receptor, 18 receptor, r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,"-"/"-" 8 8 1 0 0 0 1
cereblon. 19 cereblon. c ce cer cere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 .-, 3 9 1 0 0 0 1
installation of installation i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
scaffolds. The scaffolds. s sc sca scaf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ."-" 4 8 1 0 0 0 1
approaches will approaches a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 10 1 0 0 0 1
have low have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 . 1 7 1 0 0 0 1
Reactive fragment reactive R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 4 no 0 9 1 0 0 0 1
for the for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 8 1 0 0 0 1
interest. 21 interest. i in int inte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 9 1 0 0 0 1
enabling the enabling e en ena enab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 8 1 0 0 0 1
reactive functionality reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 -- 2 9 1 0 0 0 1
actions to actions a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 8 1 0 0 0 1
intact protein intact i in int inta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 8 1 0 0 0 1
(LC-MS) (Figure (lc-ms) ( (L (LC (LC- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 8 (-)()., 7 9 1 0 0 0 1
to a to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 9 1 0 0 0 1
interaction, including interaction, i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,(), 4 9 1 0 0 0 1
measurement of measurement m me mea meas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,- 2 9 1 0 0 0 1
target engagement. target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .,,, 4 8 1 0 0 0 1
limited to limited l li lim limi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 10 1 0 0 0 1
targets, including targets, t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,, 2 8 1 0 0 0 1
discovery of discovery d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 - 1 8 1 0 0 0 1
therapeutic AMG therapeutic t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ., 2 8 1 0 0 0 1
screening of screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 8 1 0 0 0 1
nucleophilic residues nucleophilic n nu nuc nucl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 no 0 8 1 0 0 0 1
Received: January received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 10 1 0 0 0 1
Accepted: April accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 8 1 0 0 0 1
Published: April published: P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 :, 2 9 1 0 0 0 1
Articles Articles articles A Ar Art Arti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 1 1 0 0 1
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ../ 3 10 1 1 0 0 1
© 2023 © © © © © BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 11 . 1 10 1 1 0 0 0
American Chemical american A Am Ame Amer BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 7 1 1 0 0 0
1926 1926 1926 1 19 192 1926 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 0 11 no 0 10 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 11 ://././. 8 10 1 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 0 11 ..,,- 5 8 1 1 0 0 0
This article this T Th Thi This BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 -. 2 10 1 1 0 0 1
proteins that proteins p pr pro prot BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 1 0 0 1
technologies. technologies. technologies. t te tec tech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 2 1 1 0 0 1
Here, we here, H He Her Here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 1 1 0 0 1
for the for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 10 1 1 0 0 1
This approach this T Th Thi This BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 1 0 0 1
multiple protein multiple m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 10 1 1 0 0 1
a cysteine a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 1 .- 2 9 1 1 0 0 1
chemistry direct-to-biology chemistry c ch che chem BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 --(-), 6 9 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ..() 4 9 1 0 0 0 1
the covalent the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,-.() 5 10 1 0 0 0 1
mechanism associated mechanism m me mec mech BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ---. 4 9 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 .-.()-- 7 9 1 0 0 0 1
considered for considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .()-- 5 9 1 0 0 0 1
subsequent screening subsequent s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .(), 4 9 1 0 0 0 1
KRAS4B G12D kras4b K KR KRA KRAS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ,,--.:[]. 9 10 1 0 0 0 1
CAII, 1 caii, C CA CAI CAII BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ,,[],,(). 9 5 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 10 no 0 10 1 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ../ 3 10 1 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 2 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 ..,,- 5 8 0 1 0 0 0
1927 1927 1927 1 19 192 1927 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 1 0 0 0
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 .(),, 5 9 1 0 0 0 1
modification efficiencies modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .() 3 8 1 0 0 0 1
displacement SF displacement d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .:.;;.()/ 9 8 1 0 0 0 1
spectrum of spectrum s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 *.()- 5 8 1 0 0 0 1
crystal structure crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 (:), 4 8 1 0 0 0 1
cofactor and cofactor c co cof cofa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .()( 4 9 1 0 0 0 1
single exponential single s si sin sing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 )--.: 5 8 1 0 0 0 1
[protein] = [protein] [ [p [pr [pro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 [].,[],,,,,-,.() 16 8 1 0 0 0 1
2b-e to 2b-e 2 2b 2b- 2b-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -.(),,/ 7 10 1 0 0 0 1
SFs 2b-e. sfs S SF SFs SFs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -. 2 0 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 10 no 0 10 1 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ../ 3 10 1 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 10 no 0 2 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 1 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 11 ..,,- 5 8 0 1 0 0 0
1928 1928 1928 1 19 192 1928 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 1 11 no 0 10 0 1 0 0 0
an expedient an a an an an BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 no 0 10 0 1 0 0 1
generation of generation g ge gen gene BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -.- 3 8 0 1 0 0 1
■ RESULTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
The SF-based the T Th The The BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
developed in developed d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 :, 2 8 0 0 0 0 1
appropriate SF appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
of this of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
modular library modular m mo mod modu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
amine-functionalized fragments amine-functionalized a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -- 2 9 0 0 0 0 1
moiety. Three moiety. m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
intrinsic reactivities, intrinsic i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
functionalities. 14 functionalities. f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 10 0 0 0 0 1
(meta-substituted) and (meta-substituted) ( (m (me (met BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (-)(- 5 9 0 0 0 0 1
spacer), as spacer), s sp spa spac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ),(-) 5 9 0 0 0 0 1
(Figure 2a). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 2 0 0 0 0 1
HTC Synthesis htc H HT HTC HTC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -. 2 7 0 0 0 0 1
An HTC an A An An An BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
libraries was libraries l li lib libr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
fragments in fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -. 2 9 0 0 0 0 1
D2B format d2b D D2 D2B D2B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
requirement for requirement r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
fragment library fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 4 0 0 0 0 1
A succinimide-activated a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 0 -() 3 7 0 0 0 0 1
employed using employed e em emp empl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()-- 4 8 0 0 0 0 1
morpholine (NEM) morpholine m mo mor morp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (),. 4 9 0 0 0 0 1
The conditions the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
amine-functionalized fragments amine-functionalized a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -- 2 9 0 0 0 0 1
moieties (1a, moieties m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,,)/ 5 8 0 0 0 0 1
water (9:1) water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (:) 3 8 0 0 0 0 1
reaction conditions. reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
esters 2a esters e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
products and products p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 9 0 0 0 0 1
OSu ester osu O OS OSu OSu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
SF group sf S SF SF SF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ()., 4 9 0 0 0 0 1
compounds 2a compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
longer incubation longer l lo lon long BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
slowly hydrolyze slowly s sl slo slow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
conditions. As conditions. c co con cond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
h reaction h h h h h BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
protein-containing buffer protein-containing p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
hydrolysis of hydrolysis h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 4 0 0 0 0 1
Two 352-membered two T Tw Two Two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 -- 2 8 0 0 0 0 1
subsequently synthesized subsequently s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
moiety 2 moiety m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -. 2 9 0 0 0 0 1
amine-functionalized fragments amine-functionalized a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
compound collection compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
properties (aromatic properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (;/; 4 8 0 0 0 0 1
atoms ≤ atoms a at ato atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ;) 2 9 0 0 0 0 1
chemical diversity chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ( 1 9 0 0 0 0 1
Figure S3). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ). 2 9 0 0 0 0 1
under basic under u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
LC-MS analysis lc-ms L LC LC- LC-M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 -, 2 9 0 0 0 0 1
h. Thus, h. h h. h. h. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .,- 3 9 0 0 0 0 1
at random, at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 0 0 0 0 1
products, and products, p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 7 0 0 0 0 1
reproducible across reproducible r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
separate occasions separate s se sep sepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 8 0 0 0 0 1
reproducibility observed reproducibility r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
D2B protocols d2b D D2 D2B D2B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
reactive fragments. reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 3 0 0 0 0 1
D2B Screening d2b D D2 D2B D2B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
A panel a A A A A BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
reactive fragment reactive r re rea reac BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 :,,. 4 8 0 0 0 0 1
These proteins these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
diversity and diversity d di div dive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
relevance. None relevance. r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
amino acid amino a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
SFs in sfs S SF SFs SFs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
vicinity of vicinity v vi vic vici BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 4 0 0 0 0 1
Initially, the initially, I In Ini Init BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 ,,- 3 7 0 0 0 0 1
substituted aryl substituted s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
three proteins three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (,) 3 8 0 0 0 0 1
analyzed by analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -(. 3 8 0 0 0 0 1
20 or 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 )()., 5 8 0 0 0 0 1
of wells of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,- 2 8 0 0 0 0 1
reactive moieties reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
modifications. However, modifications. m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,, 3 8 0 0 0 0 1
mass spectra mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
consistent with consistent c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
SF fragment, sf S SF SF SF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
the reaction the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
the SF the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 :[-]. 5 8 0 0 0 0 1
yields were yields y yi yie yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
defined as defined d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
deviations. Hits deviations. d de dev devi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 8 0 0 0 0 1
extent of extent e ex ext exte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
than 50% than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (..,-), 7 7 0 0 0 0 1
modification less modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (..,-)(). 9 9 0 0 0 0 1
All hits all A Al All All BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
consistent with consistent c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -.- 3 8 0 0 0 0 1
ing reactive ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
were resynthesized were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
tigations. Disappointingly, tigations. t ti tig tiga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ., 2 7 0 0 0 0 1
KRAS G12D kras K KR KRA KRAS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
be a be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .- 2 9 0 0 0 0 1
reactive sulfamoyl reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
afforded no afforded a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 10 0 0 0 0 1
the electrophile. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 2 0 0 0 0 1
Site(s) of site(s) S Si Sit Site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 (). 3 8 0 0 0 0 1
(CAII) is (caii) ( (C (CA (CAI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 () 2 8 0 0 0 0 1
of carbon of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
inhibitors have inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
oedema, and oedema, o oe oed oede BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ,., 3 9 0 0 0 0 1
aromatic sulfonamide aromatic a ar aro arom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
Zn 2+ zn Z Zn Zn Zn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 5 0 0 0 0 1
The HTC-D2B the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 -(-) 4 7 0 0 0 0 1
with modification with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -(). 4 8 0 0 0 0 1
these hits these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
known inhibitors, known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,() 3 8 0 0 0 0 1
sulfonamide, of sulfonamide, s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ,. 2 8 0 0 0 0 1
compounds were compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
yield of yield y yi yie yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
and high and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 7 0 0 0 0 1
The site the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 7 0 0 0 0 1
studies. 34 studies. s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
(4) (K (4) ( (4 (4) (4) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 ()(), 5 8 0 0 0 0 1
pocket. 31 pocket. p po poc pock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .() 3 8 0 0 0 0 1
coincubated with coincubated c co coi coin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 () 2 8 0 0 0 0 1
a control, a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 1 5 ,(.). 5 9 0 0 0 0 1
spectra after spectra s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
ethoxzolamide had ethoxzolamide e et eth etho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
2b-e, indicating 2b-e, 2 2b 2b- 2b-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -,(). 5 7 0 0 0 0 1
Tandem MS tandem T Ta Tan Tand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 7 0 0 0 0 1
identification of identification i id ide iden BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 () 2 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 2 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 11 ..,,- 5 8 0 1 0 0 0
1929 1929 1929 1 19 192 1929 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 2 11 no 0 10 0 1 0 0 0
modified. Samples modified. m mo mod modi BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
purified SFs purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
analyzed by analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -/.- 4 8 0 0 0 0 1
GH*AFNVEFDDSQDKAVLK 80 gh*afnvefddsqdkavlk G GH GH* GH*A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 **- 3 6 0 0 0 0 1
VEFDDSQDK 76 vefddsqdk V VE VEF VEFD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 8 0 0 0 0 1
His64 for his64 H Hi His His6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ()()() 6 9 0 0 0 0 1
(Figure 3b), (figure ( (F (Fi (Fig BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (),., 5 10 0 0 0 0 1
were observed were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 8 0 0 0 0 1
His3 (2d his3 H Hi His His3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 ()(). 5 5 0 0 0 0 1
To rationalize to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 8 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 9 0 0 0 0 1
mode of mode m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (:)., 5 8 0 0 0 0 1
indicated that indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 10 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 , 1 9 0 0 0 0 1
away, and away, a aw awa away BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ,( 2 9 0 0 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 ..()(- 6 9 1 0 0 0 1
functionalized analogues functionalized f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ,).()- 6 9 1 0 0 0 1
workflow used workflow w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 .(), 4 10 1 0 0 0 1
proteins. (d) proteins. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .(),. 5 9 1 0 0 0 1
correspond to correspond c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 :.;-..(), 9 9 1 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .:.;-..() 9 9 1 0 0 0 1
difference between difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 //,.() 6 9 1 0 0 0 1
between probe between b be bet betw BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 //,. 4 5 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 no 0 10 1 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 ../ 3 10 1 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 2 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 3 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 11 ..,,- 5 8 0 1 0 0 0
1930 1930 1930 1 19 193 1930 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 3 11 no 0 10 0 1 0 0 0
S7). 35 s7). S S7 S7) S7). BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ).,,- 5 9 0 0 0 0 1
observed, and observed, o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 0 0 0 0 1
as residues as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
minor modifications minor m mi min mino BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 (). 3 5 0 0 0 0 1
Kinetic Analyses kinetic K Ki Kin Kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 0 0 0 1
were investigated were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
purified SFs purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
analysis by analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -( 2 8 0 0 0 0 1
Figure S9). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ).- 3 8 0 0 0 0 1
on a on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -() 3 8 0 0 0 0 1
subsequent irreversible subsequent s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
(P) (P (p) ( (P (P) (P) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ()(•)(). 8 8 0 0 0 0 1
were fit were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
concentration (Figure concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 0 0 0 0 1
Michaelis-Menten model michaelis-menten M Mi Mic Mich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -( 2 8 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -)( 3 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 )( 2 9 0 0 0 0 1
3e,f). All 3e,f). 3 3e 3e, 3e,f BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ,). 3 8 0 0 0 0 1
affinity (K affinity a af aff affi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (), 3 9 0 0 0 0 1
screened for screened s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 0 0 0 0 1
strong binding strong s st str stro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
pocket. 33 pocket. p po poc pock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 0 0 0 1
covalent modification, covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
between 6.5 between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ... 3 8 0 0 0 0 1
rate of rate r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
trajectory of trajectory t tr tra traj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
reversible bound reversible r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 / 1 8 0 0 0 0 1
the residue. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 2 0 0 0 0 1
An advantage an A An An An BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 0 - 1 7 0 0 0 0 1
screening strategy screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
libraries of libraries l li lib libr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
original hits original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .- 2 9 0 0 0 0 1
faster design-make-test faster f fa fas fast BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
methods in methods m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 0 0 0 1
efficient identification efficient e ef eff effi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
explore whether explore e ex exp expl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
ments would ments m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
new library new n ne new new BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .,- 3 8 0 0 0 0 1
fragment analogues fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -, 2 8 0 0 0 0 1
OSu ester osu O OS OSu OSu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
CAII for caii C CA CAI CAII BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -. 2 8 0 0 0 0 1
Inspection of inspection I In Ins Insp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
incubation revealed incubation i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
significantly higher significantly s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (, 2 8 0 0 0 0 1
S11) when s11) S S1 S11 S11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 )(, 3 8 0 0 0 0 1
Figure 3d). figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 ). 2 8 0 0 0 0 1
particularly notable particularly p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -- 2 8 0 0 0 0 1
D2B library d2b D D2 D2B D2B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 7 0 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 9 0 0 0 0 1
The improvement the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
HTC-D2B approach htc-d2b H HT HTC HTC- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 - 1 8 0 0 0 0 1
parameters, with parameters, p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,() 3 9 0 0 0 0 1
and also and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
Assessment of assessment A As Ass Asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 0 0 0 0 1
Hits. Hits hits. H Hi Hit Hits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 7 0 0 0 0 1
chemoproteomic profiling chemoproteomic c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 9 0 0 0 0 1
ment and ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -. 2 9 0 0 0 0 1
were functionalized were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
group to group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
control was control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
for a for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,(). 4 8 0 0 0 0 1
first incubated first f fi fir firs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
and 2k and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
alkyne group alkyne a al alk alky BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
control 2l control c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
were subsequently were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 6 0 0 0 0 1
HEK293T cells hek293t H HE HEK HEK2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,, 2 9 0 0 0 0 1
(10 μM) (10 ( (1 (10 (10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ().-- 5 8 0 0 0 0 1
ments were ments m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
parent hits parent p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 ()(), 5 8 0 0 0 0 1
addition of addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -()( 4 8 0 0 0 0 1
μM), respectively. μm), μ μM μM) μM), BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ),., 4 8 0 0 0 0 1
lysed and lysed l ly lys lyse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 --, 3 8 0 0 0 0 1
biotinylated proteins biotinylated b bi bio biot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
Enriched proteins enriched E En Enr Enri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
to analysis to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -/(). 5 5 0 0 0 0 1
All three all A Al All All BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 (-) 3 8 0 0 0 0 1
proteins by proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (,, 3 8 0 0 0 0 1
447, respectively, 447, 4 44 447 447, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,,.,-.,# 8 9 0 0 0 0 1
peptides ≥2), peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ), 2 8 0 0 0 0 1
fragments in fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 0 0 0 1
observed between observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
indicating that indicating i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
moiety, rather moiety, m mo moi moie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,( 2 9 0 0 0 0 1
4c). The 4c). 4 4c 4c) 4c). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 )., 3 9 0 0 0 0 1
APMAP, and apmap, A AP APM APMA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ,. 2 8 0 0 0 0 1
and CRABP2 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
reaction at reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 10 0 0 0 0 1
some enrichment some s so som some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
poorly resolved poorly p po poo poor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 0 0 0 1
further investigate further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
containing active containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (), 3 9 0 0 0 0 1
the enriched the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
containing negative containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (). 3 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
aryl sulfonamide aryl a ar ary aryl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
ment of ment m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (,). 4 4 0 0 0 0 1
Interestingly, competition interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
showed relatively showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
suggesting that suggesting s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 9 0 0 0 0 1
metric binding. metric m me met metr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ., 2 9 0 0 0 0 1
2j nor 2j 2 2j 2j 2j BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 , 1 7 0 0 0 0 1
respectively. This respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
modification of modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
analyses, which analyses, a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
partially modified partially p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ., 2 8 0 0 0 0 1
results indicate results r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
did engage did d di did did BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
poor selectivity poor p po poo poor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -. 2 7 0 0 0 0 1
Further investigation further F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
proteins were proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
high levels high h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 ;,, 3 8 0 0 0 0 1
ABHD6, and abhd6, A AB ABH ABHD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ,(,). 5 7 0 0 0 0 1
catalyze the catalyze c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,, 2 9 0 0 0 0 1
and have and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
react with react r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .,, 3 8 0 0 0 0 1
phospholipid binder phospholipid p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
of serine of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ., 2 10 0 0 0 0 1
proteins bind proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
consistent with consistent c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 0 0 0 1
probes targeting probes p pr pro prob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
for these for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
SF group sf S SF SF SF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
bound by bound b bo bou boun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
targets suggest targets t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 0 0 0 0 1
of potent of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -. 2 5 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 4 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 4 11 ..,,- 5 8 0 1 0 0 0
1931 1931 1931 1 19 193 1931 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 11 no 0 10 0 1 0 0 0
BCL6 Follow-Up bcl6 B BC BCL BCL6 BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -:() 4 7 1 0 0 0 1
Expansion. The expansion. E Ex Exp Expa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 .- 2 8 1 0 0 0 1
(BCL6) has (bcl6) ( (B (BC (BCL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 () 2 8 1 0 0 0 1
lymphoid malignancies. lymphoid l ly lym lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 .- 2 9 1 0 0 0 1
protein interactions protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 10 1 0 0 0 1
interactions is interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
cancer treatment. cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 1 0 0 0 1
BCL6 have bcl6 B BC BCL BCL6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
as compound as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 7 1 0 0 0 1
12. 41,42 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ., 2 9 1 0 0 0 1
been reported, been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(- 3 9 1 0 0 0 1
3802) and 3802) 3 38 380 3802 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ) 1 9 1 0 0 0 1
14 (TMX-2164) 14 1 14 14 14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 (-)(,)., 8 8 1 0 0 0 1
The top the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
distinct chemotypes: distinct d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 :-() 4 9 1 0 0 0 1
and azetidine and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 7 1 0 0 0 1
resynthesized and resynthesized r re res resy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -. 2 9 1 0 0 0 1
was used was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 () 2 9 1 0 0 0 1
covalent modification, covalent c co cov cova BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,, 2 9 1 0 0 0 1
chemotypes were chemotypes c ch che chem BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ( 1 10 1 0 0 0 1
5c,d). The 5c,d). 5 5c 5c, 5c,d BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ,).- 4 9 1 0 0 0 1
(373 Da) (373 ( (3 (37 (373 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 3 ()() 4 8 1 0 0 0 1
47 TVLMACSGLFY*SIFTDQLKR 47 4 47 47 47 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 4 *, 2 9 0 0 0 0 1
2h (365 2h 2 2h 2h 2h BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 ()() 4 10 0 0 0 0 1
98 EGNIMAVMATAMYLQMEH*VVDTCR 98 9 98 98 98 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 4 *( 2 7 0 0 0 0 1
S12). Tyr57 s12). S S1 S12 S12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 ). 2 9 0 0 0 0 1
(14, TMX-2164); (14, ( (1 (14 (14, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 (,-);, 6 9 0 0 0 0 1
modification; these modification; m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ; 1 9 0 0 0 0 1
the binding the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 (- 2 9 0 0 0 0 1
14) (see 14) 1 14 14) 14) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 )(). 4 3 0 0 0 0 1
An iterative an A An An An BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 4 no 0 9 0 0 0 0 1
intention of intention i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 8 0 0 0 0 1
identifying BCL6 identifying i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 . 1 10 0 0 0 0 1
For this, for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 ,-- 3 9 0 0 0 0 1
fragments was fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 8 0 0 0 0 1
available amine-functionalized available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 - 1 9 0 0 0 0 1
original hits original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 (-)., 5 8 0 0 0 0 1
incubated with incubated i in inc incu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 , 1 8 0 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 ..()-.() 8 9 1 0 0 0 1
compound 13 compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (-)/,(:). 9 8 1 0 0 0 1
(c) Summary (c) ( (c (c) (c) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ().; 4 9 1 0 0 0 1
colored blue. colored c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 .()-:-()/ 9 9 1 0 0 0 1
piperidinyl fragments piperidinyl p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ().(). 6 10 1 0 0 0 1
of original of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 :[],[],,.:[],[],,. 18 9 1 0 0 0 1
dashed line dashed d da das dash BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ;.()-. 6 9 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 no 0 10 1 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 ../ 3 10 1 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 2 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 5 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 ..,,- 5 8 0 1 0 0 0
1932 1932 1932 1 19 193 1932 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 11 no 0 10 0 1 0 0 0
analyzed by analyzed a an ana anal BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 8 0 0 0 0 1
modifications observed modifications m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
with many with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (-). 4 9 0 0 0 0 1
reactive fragments reactive r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
greater than greater g gr gre grea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
original screen original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
(Figure 5e,f). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,).- 5 8 0 0 0 0 1
higher modification higher h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
meta position meta m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 5 0 -. 2 8 0 0 0 0 1
different N-containing different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 9 0 0 0 0 1
heteroatom links heteroatom h he het hete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
binding pocket. binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 2 0 0 0 0 1
Structural and structural S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
Hits. With hits. H Hi Hit Hits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ., 2 10 0 0 0 0 1
we sought we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
information to information i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
bind to bind b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
purified: the purified: p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :(-) 4 10 0 0 0 0 1
the iterative the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (,,,). 6 10 0 0 0 0 1
eight hits eight e ei eig eigh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 10 0 0 0 0 1
binders, GSK137 binders, b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,() 3 8 0 0 0 0 1
known inhibitor known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
(100 μM) (100 ( (1 (10 (100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 () 2 9 0 0 0 0 1
of GSK137 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (), 3 8 0 0 0 0 1
were analyzed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 8 0 0 0 0 1
spectra showed spectra s sp spe spec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
78-96% for 78-96% 7 78 78- 78-9 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -, 2 8 0 0 0 0 1
competing for competing c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 (). 3 6 0 0 0 0 1
We subsequently we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 - 1 8 0 0 0 0 1
using differential using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 () 2 9 0 0 0 0 1
impact of impact i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 . 1 9 0 0 0 0 1
azetidinyl/piperidinyl fragments azetidinyl/piperidinyl a az aze azet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 / 1 9 0 0 0 0 1
shifts (see shifts s sh shi shif BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 (,);,- 6 9 0 0 0 0 1
benzamide complexes benzamide b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 ( 1 9 0 0 0 0 1
7 °C) 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 3 ), 2 8 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
(Figure 6b). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 (). 3 10 0 0 0 0 1
observed for observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ,( 2 9 0 0 0 0 1
∼ 12 ∼ ∼ ∼ ∼ ∼ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 3 ,). 3 10 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 (-)- 4 9 0 0 0 0 1
substituted benzamides, substituted s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 , 1 9 0 0 0 0 1
fragments were fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 , 1 9 0 0 0 0 1
2f and 2f 2 2f 2f 2f BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 ,()., 5 9 0 0 0 0 1
interesting to interesting i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 9 0 0 0 0 1
with biochemical with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ; 1 9 0 0 0 0 1
covalent modification covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 3 -. 2 7 0 0 0 0 1
Crystal structures crystal C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 8 0 0 0 0 1
generated to generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 8 0 0 0 0 1
fragments; this fragments; f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 ;. 2 8 0 0 0 0 1
Cocrystal structures cocrystal C Co Coc Cocr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 (. 2 9 0 0 0 0 1
and 1.8 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .,) 3 9 0 0 0 0 1
conjugated to conjugated c co con conj BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 , 1 9 0 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 ..() 4 9 1 0 0 0 1
abolishes covalent abolishes a ab abo abol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -/.()- 6 9 1 0 0 0 1
substituted benzamide substituted s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ..() 4 10 1 0 0 0 1
Cocrystal structure cocrystal C Co Coc Cocr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 /.;. 4 8 1 0 0 0 1
shown in shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .()/. 5 9 1 0 0 0 1
is shown is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 ;..() 5 9 1 0 0 0 1
crystal structures crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 7 . 1 9 1 0 0 0 1
clarity. Compounds clarity. c cl cla clar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 .,,.() 6 9 1 0 0 0 1
structures of structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 (:).. 5 9 1 0 0 0 1
Compounds GSK137 compounds C Co Com Comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 ,,. 3 7 1 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 no 0 10 1 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 ../ 3 10 1 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 2 1 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 5 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 5 11 ..,,- 5 8 0 1 0 0 0
1933 1933 1933 1 19 193 1933 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 5 11 no 0 10 0 1 0 0 0
with tandem with w wi wit with BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (,). 4 9 0 0 0 0 1
Arg27 was arg27 A Ar Arg Arg2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
groups of groups g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
modification of modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 9 0 0 0 0 1
While the while W Wh Whi Whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
opposite trajectories, opposite o op opp oppo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 8 0 0 0 0 1
benzamide aryl benzamide b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 , 1 8 0 0 0 0 1
trisubstituted aryl trisubstituted t tr tri tris BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (). 3 10 0 0 0 0 1
The twisted the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
premodified state premodified p pr pre prem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -, 2 8 0 0 0 0 1
have become have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
Tyr57 to tyr57 T Ty Tyr Tyr5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 . 1 8 0 0 0 0 1
structures of structures s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 , 1 9 0 0 0 0 1
two binding two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
crystallographic state crystallographic c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (). 3 10 0 0 0 0 1
have similar have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 / 1 9 0 0 0 0 1
POZ domain. poz P PO POZ POZ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 2 0 0 0 0 1
■ CONCLUSIONS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 1 no 0 10 0 0 0 0 1
Covalent inhibitors covalent C Co Cov Cova BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
drug discovery drug d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
liganding challenging liganding l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
efforts to efforts e ef eff effo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
targeting of targeting t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
However, to however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 8 0 0 0 0 1
validated targets validated v va val vali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 9 0 0 0 0 1
approaches to approaches a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
cysteine are cysteine c cy cys cyst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
target a target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
are effective are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 "- 2 8 0 0 0 0 1
cysteine" covalent cysteine" c cy cys cyst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 ".,- 4 9 0 0 0 0 1
probes have probes p pr pro prob BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 - 1 8 0 0 0 0 1
guided approaches; guided g gu gui guid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ; 1 9 0 0 0 0 1
SF group sf S SF SF SF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 ., 2 8 0 0 0 0 1
demonstrated that demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 - 1 9 0 0 0 0 1
expedient approach expedient e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 "-" 3 8 0 0 0 0 1
covalent ligands. covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 2 0 0 0 0 1
Screening a screening S Sc Scr Scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
two of two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 8 0 0 0 0 1
interact with interact i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 8 0 0 0 0 1
screening with screening s sc scr scre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
fragments is fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 () 2 9 0 0 0 0 1
modification using modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
to modify to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 9 0 0 0 0 1
histidine modification histidine h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
perhaps surprising perhaps p pe per perh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
histidine adducts histidine h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 8 0 0 0 0 1
examples of examples e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
is not is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
targeting histidine targeting t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 .,,, 4 6 0 0 0 0 1
Kinetic analyses kinetic K Ki Kin Kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
covalent modification covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 10 0 0 0 0 1
Interestingly, the interestingly, I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 ,- 2 8 0 0 0 0 1
covalent affinity covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 () 2 9 0 0 0 0 1
(k inact (k ( (k (k (k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 (). 3 8 0 0 0 0 1
histidine residue histidine h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 no 0 7 0 0 0 0 1
modification. An modification. m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 .- 2 8 0 0 0 0 1
original hits original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
modification (>70% modification m mo mod modi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (),- 4 8 0 0 0 0 1
lighting the lighting l li lig ligh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 0 0 0 1
reactivity in reactivity r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 - 1 8 0 0 0 0 1
and K and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 . 1 1 0 0 0 0 1
The chemoproteomic the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
they engaged they t th the they BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,,, 3 8 0 0 0 0 1
likely due likely l li lik like BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 9 0 0 0 0 1
hits and hits h hi hit hits BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
many additional many m ma man many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 5 (), 3 9 0 0 0 0 1
common to common c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 8 0 0 0 0 1
specificity is specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
developing SF-based developing d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -. 2 8 0 0 0 0 1
has demonstrated has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
highly tunable. highly h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ., 2 9 0 0 0 0 1
target engagement target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
reduction of reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
k inact k k k k k BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 6 5 .- 2 9 0 0 0 0 1
here provides here h he her here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 7 0 0 0 0 1
optimization. optimization. optimization. o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 2 0 0 0 0 1
The SF the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
a therapeutic a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
blood, breast, blood, b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,,., 4 9 0 0 0 0 1
afforded two afforded a af aff affo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
residues on residues r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 8 0 0 0 0 1
tyrosine and tyrosine t ty tyr tyro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
the approach the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
within a within w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ., 2 8 0 0 0 0 1
compounds was compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 9 0 0 0 0 1
attenuation of attenuation a at att atte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,, 2 9 0 0 0 0 1
the fragments the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -. 2 9 0 0 0 0 1
Cocrystal structures cocrystal C Co Coc Cocr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 , 1 8 0 0 0 0 1
which confirmed which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
with that with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
to aid to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 / 1 9 0 0 0 0 1
domain. domain. domain. d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 1 0 0 0 0 1
Collectively, these collectively, C Co Col Coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 ,- 2 8 0 0 0 0 1
fragment screening fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 8 0 0 0 0 1
discovery of discovery d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 "-".- 5 8 0 0 0 0 1
D2B approach d2b D D2 D2B D2B BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 -- 2 9 0 0 0 0 1
to drive to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 9 0 0 0 0 1
HTC-D2B workflow htc-d2b H HT HTC HTC- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 - 1 9 0 0 0 0 1
SF groups sf S SF SF SF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 , 1 9 0 0 0 0 1
reduce the reduce r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,, 2 9 0 0 0 0 1
fragments while fragments f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 10 0 0 0 0 1
target of target t ta tar targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 8 0 0 0 0 1
covalent chemical covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
ultimately further ultimately u ul ult ulti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 . 1 8 0 0 0 0 1
■ METHODS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 9 no 0 10 0 0 0 0 1
Full experimental full F Fu Ful Full BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 no 0 10 0 0 0 0 1
provided in provided p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 . 1 5 0 0 0 0 1
HTC-D2B Protocol. htc-d2b H HT HTC HTC- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 -.-- 4 8 0 0 0 0 1
functionalized fragments functionalized f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 ()() 4 8 0 0 0 0 1
added a added a ad add adde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ()() 4 8 0 0 0 0 1
DMSO (5 dmso D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 ().,(, 6 9 0 0 0 0 1
1000 rpm), 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 9 ),. 3 9 0 0 0 0 1
reaction (assumed reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 (:), 4 9 0 0 0 0 1
to a to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 . 1 10 0 0 0 0 1
protein (see protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 () 2 9 0 0 0 0 1
subsequently added subsequently s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ., 2 8 0 0 0 0 1
centrifuged, incubated centrifuged, c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 ,, 2 9 0 0 0 0 1
LC-MS. LC-MS. lc-ms. L LC LC- LC-M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 9 -. 2 1 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 .( 2 9 0 0 0 0 1
and purified) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 )(,)- 5 9 0 0 0 0 1
plate. Purified plate. p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 .. 2 9 0 0 0 0 1
concentrations: 2 concentrations: c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 :;., 4 8 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 7 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 7 11 ..,,- 5 8 0 1 0 0 0
1934 1934 1934 1 19 193 1934 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 11 no 0 10 0 1 0 0 0
centrifuged, and centrifuged, c ce cen cent BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,, 2 9 0 0 0 0 1
subsequently removed subsequently s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -. 2 8 0 0 0 0 1
remaining samples remaining r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ()- 3 9 0 0 0 0 1
polyacrylamide gel polyacrylamide p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
compounds. Gels compounds. c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 0 0 0 0 1
and bands and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 0 0 0 0 1
(10 mM, (10 ( (1 (10 (10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (,,),(, 7 9 0 0 0 0 1
rt, 30 rt, r rt rt, rt, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,).(:/, 8 9 0 0 0 0 1
°C, 16 °c, ° °C °C, °C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,)(). 5 9 0 0 0 0 1
supernatant, peptides supernatant, s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,. 2 9 0 0 0 0 1
supernatants were supernatants s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 0 0 0 1
LC-MS/MS system. lc-ms/ms L LC LC- LC-M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -/. 3 8 0 0 0 0 1
matches against matches m ma mat matc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
trypsin as trypsin t tr try tryp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .[-] 4 8 0 0 0 0 1
allowed as allowed a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (),,, 5 9 0 0 0 0 1
tyrosine, serine, tyrosine, t ty tyr tyro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,,-./ 5 9 0 0 0 0 1
MS spectra ms M MS MS MS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 6 0 0 0 0 1
Kinetic Analyses. kinetic K Ki Kin Kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 .()(- 5 8 0 0 0 0 1
e, 10 e, e e, e, e, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,)- 3 8 0 0 0 0 1
make up make m ma mak make BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,,,, 4 9 0 0 0 0 1
or 5 or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 0 0 0 0 1
percentage of percentage p pe per perc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 7 0 0 0 0 1
subsequently added subsequently s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .. 2 9 0 0 0 0 1
μM protein; μm μ μM μM μM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ;,,,,. 6 9 0 0 0 0 1
centrifuged, and centrifuged, c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 0 0 0 0 1
analysis by analysis a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 0 0 0 0 1
final plate final f fi fin fina BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 5 0 0 0 0 1
■ ASSOCIATED ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 no 0 10 0 0 0 0 1
* sı * * * * * BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 2 * 1 10 0 0 0 0 1
The Supporting the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 10 0 0 0 0 1
https://pubs.acs.org/doi/10.1021/acschembio.3c00034. https://pubs.acs.org/doi/10.1021/acschembio.3c00034. https://pubs.acs.org/doi/10.1021/acschembio.3c00034. h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 7 2 ://..//./.. 11 9 0 0 0 0 1
Full details full F Fu Ful Full BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 8 0 0 0 0 1
compound synthesis compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 , 1 9 0 0 0 0 1
structures, summary structures, s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,-, 3 8 0 0 0 0 1
properties, summary properties, p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,,/ 3 8 0 0 0 0 1
spectrum, crystalography, spectrum, s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,,,- 4 9 0 0 0 0 1
step binding step s st ste step BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,, 2 9 0 0 0 0 1
DSF traces, dsf D DS DSF DSF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ,, 2 10 0 0 0 0 1
studies (PDF) studies s st stu stud BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 () 2 2 0 0 0 0 1
■ AUTHOR ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 3 no 0 10 0 0 0 0 1
Corresponding Authors corresponding C Co Cor Corr BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 no 0 10 0 0 0 0 1
Nicholas C. nicholas N Ni Nic Nich BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 3 ..- 3 8 0 0 0 0 1
Applied Chemistry, applied A Ap App Appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 ,, 2 10 0 0 0 0 1
1XL, U.K.; 1xl, 1 1X 1XL 1XL, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 ,..;./---; 10 7 0 0 0 0 1
Email: nicholas.tomkinson@strath.ac.uk email: E Em Ema Emai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 :.@.. 5 6 0 0 0 0 1
Jacob T. jacob J Ja Jac Jaco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 3 .-,,, 5 9 0 0 0 0 1
U.K.; The u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 3 ..;,,..; 8 10 0 0 0 0 1
orcid.org/0000-0001-7165-0092; Email: orcid.org/0000-0001-7165-0092; o or orc orci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 ./---;:..@ 10 9 0 0 0 0 1
gsk.com gsk.com gsk.com g gs gsk gsk. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 . 1 1 0 0 0 0 1
Authors Authors authors A Au Aut Auth BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 10 0 0 0 0 1
Arron Aatkar arron A Ar Arr Arro BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 4 -,,, 4 8 0 0 0 0 1
U.K.; Department u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 ..;, 4 10 0 0 0 0 1
of Strathclyde, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,,.. 4 6 0 0 0 0 1
Aini Vuorinen aini A Ai Ain Aini BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 -,,, 4 9 0 0 0 0 1
U.K.; The u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 ..;,,.. 7 9 0 0 0 0 1
Oliver E. oliver O Ol Oli Oliv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 4 .-,, 4 9 0 0 0 0 1
2NY, U.K.; 2ny, 2 2N 2NY 2NY, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 ,..;, 5 8 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 ,,.. 4 8 0 0 0 0 1
Katharine Gilbert katharine K Ka Kat Kath BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 4 -,,, 4 9 0 0 0 0 1
U.K.; Department u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 ..;, 4 10 0 0 0 0 1
of Strathclyde, of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,,.. 4 6 0 0 0 0 1
Rachel Peltier-Heap rachel R Ra Rac Rach BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 5 --,, 4 9 0 0 0 0 1
19426, United 19426, 1 19 194 1942 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 , 1 3 0 0 0 0 1
Craig D. craig C Cr Cra Crai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 5 .-,,, 5 9 0 0 0 0 1
United States united U Un Uni Unit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 2 0 0 0 0 1
Francesca Zappacosta francesca F Fr Fra Fran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 5 -,, 3 9 0 0 0 0 1
19426, United 19426, 1 19 194 1942 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 , 1 3 0 0 0 0 1
Katrin Rittinger katrin K Ka Kat Katr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 -, 2 10 0 0 0 0 1
1AT, U.K.; 1at, 1 1A 1AT 1AT, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ,..;./--- 9 7 0 0 0 0 1
Chun-wa Chung chun-wa C Ch Chu Chun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 --,,, 5 9 0 0 0 0 1
U.K.; orcid.org/0000-0002-2480-3110 u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ..;./--- 8 6 0 0 0 0 1
David House david D Da Dav Davi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 5 -,,, 4 8 0 0 0 0 1
U.K.; The u.k.; U U. U.K U.K. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ..;,,..; 8 9 0 0 0 0 1
orcid.org/0000-0002-9635-2451 orcid.org/0000-0002-9635-2451 orcid.org/0000-0002-9635-2451 o or orc orci BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 ./--- 5 5 0 0 0 0 1
Complete contact complete C Co Com Comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 : 1 9 0 0 0 0 1
https://pubs.acs.org/10.1021/acschembio.3c00034 https://pubs.acs.org/10.1021/acschembio.3c00034 https://pubs.acs.org/10.1021/acschembio.3c00034 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 7 6 ://.././. 9 10 0 0 0 0 1
Notes Notes notes N No Not Note BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 10 0 0 0 0 1
■ ACKNOWLEDGMENTS ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
The authors the T Th The The BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 / 1 8 0 0 0 0 1
Collaborative PhD collaborative C Co Col Coll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 6 no 0 8 0 0 0 0 1
resources and resources r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 - 1 9 0 0 0 0 1
ships EP/S035990/1 ships s sh shi ship BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ////. 5 7 0 0 0 0 1
supported by supported s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 10 0 0 0 0 1
funding from funding f fu fun fund BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (), 3 8 0 0 0 0 1
Research Council research R Re Res Rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 6 (), 3 7 0 0 0 0 1
(CC2075). The (cc2075). ( (C (CC (CC2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 6 ().. 4 8 0 0 0 0 1
for LC-MS for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -..,., 6 8 0 0 0 0 1
and J. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 8 0 0 0 0 1
fragments. They fragments. f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ... 3 8 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 / 1 8 0 0 0 0 1
Programme. They programme. P Pr Pro Prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 8 0 0 0 0 1
Scholarship (A. scholarship S Sc Sch Scho BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 (.). 4 3 0 0 0 0 1
■ REFERENCES ■ ■ ■ ■ ■ BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 7 no 0 10 0 0 0 0 1
(1) Mukherjee, (1) ( (1 (1) (1) BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (),.;,..: 9 8 0 0 0 0 1
developments in developments d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .. 2 8 0 0 0 0 1
Opin. Chem. opin. O Op Opi Opin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ...,,-. 7 4 0 0 0 0 1
(2) Resnick, (2) ( (2 (2) (2) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (),.;,.;,.;,.;,.; 17 9 0 0 0 0 1
Sethi, R.; sethi, S Se Set Seth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,.;,..;,.;,.;,.;, 17 9 0 0 0 0 1
J.; Fairhead, j.; J J. J.; J.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .;,.;,.;,.;,.;,.;, 18 10 0 0 0 0 1
A.; Reznik, a.; A A. A.; A.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .;,.;,..;-,.;,..;, 18 9 0 0 0 0 1
T.; Velupillai, t.; T T. T.; T.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .;,.;,.;,.;,..;,. 17 9 0 0 0 0 1
G.; Barr, g.; G G. G.; G.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .;,..;,.;,...;,..;,.; 21 9 0 0 0 0 1
Von Delft, von V Vo Von Von BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 8 7 ,.;,.- 6 8 0 0 0 0 1
Electrophile-Fragment Screening. electrophile-fragment E El Ele Elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 -.....,,- 9 9 0 0 0 0 1
8968. 8968. 8968. 8 89 896 8968 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 . 1 0 0 0 0 0 1
(3) Johansson, (3) ( (3 (3) (3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (),.;,..;,.;,..; 16 9 0 0 0 0 1
Kumper, S.; kumper, K Ku Kum Kump BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,.;,.;,..;,..;,.; 17 9 0 0 0 0 1
House, D.; house, H Ho Hou Hous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 ,.;,.- 6 9 0 0 0 0 1
Enables Rapid enables E En Ena Enab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 no 0 8 0 0 0 0 1
Ligase HOIP. ligase L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .....,,-. 9 7 0 0 0 0 1
(4) Douangamath, (4) ( (4 (4) (4) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (),.;,.;,.;,.;,.; 17 9 0 0 0 0 1
Owen, C. owen, O Ow Owe Owen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,..;,.;-,.;,.;- 15 9 0 0 0 0 1
Balogh, P.; balogh, B Ba Bal Balo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,.;-,.;,.;,.;,.; 16 9 0 0 0 0 1
Downes, T. downes, D Do Dow Down BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,..;,.;,.;,..;,..; 18 9 0 0 0 0 1
Keeley, A.; keeley, K Ke Kee Keel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,.;,..;,..;,..;,.. 18 9 0 0 0 0 1
M.; O'Brien, m.; M M. M.; M.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 .;',.;,.;,..;,.;,.; 19 8 0 0 0 0 1
Waring, M. waring, W Wa War Wari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 7 ,..;,.;,.;,.;,.. 16 8 0 0 0 0 1
Crystallographic and crystallographic C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 - 1 9 0 0 0 0 1
CoV-2 main cov-2 C Co CoV CoV- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 -...,,-. 8 7 0 0 0 0 1
(5) Jones, (5) ( (5 (5) (5) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 (),..-: 7 8 0 0 0 0 1
Targeting residues targeting T Ta Tar Targ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 7 .....,, 7 9 0 0 0 0 1
95-134. 95-134. 95-134. 9 95 95- 95-1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 -. 2 1 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 8 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 11 ..,,- 5 8 0 1 0 0 0
1935 1935 1935 1 19 193 1935 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 8 11 no 0 10 0 1 0 0 0
(6) Pettinger, (6) ( (6 (6) (6) BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,.;,..- 12 8 0 0 0 0 1
Covalent Inhibitors. covalent C Co Cov Cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ...,..,,-. 10 8 0 0 0 0 1
(7) Hett, (7) ( (7 (7) (7) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,.;,..;,.;,. 18 8 0 0 0 0 1
E.; Menard, e.; E E. E.; E.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,.;,..;,.;,.; 19 9 0 0 0 0 1
Robinson, R. robinson, R Ro Rob Robi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,..;,.. 11 8 0 0 0 0 1
active-site tyrosine active-site a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -.. 3 9 0 0 0 0 1
Biol. 2015, biol. B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .,,-. 5 3 0 0 0 0 1
(8) Shannon, (8) ( (8 (8) (8) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,.;,..;,.; 16 8 0 0 0 0 1
Hoorn, R. hoorn, H Ho Hoo Hoor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,...;,. 7 8 0 0 0 0 1
Activity-Based Probes activity-based A Ac Act Acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 -.,, 4 8 0 0 0 0 1
2327-2330. 2327-2330. 2327-2330. 2 23 232 2327 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 -. 2 1 0 0 0 0 1
(9) Dong, (9) ( (9 (9) (9) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,.;,..;,..() 17 9 0 0 0 0 1
fluoride exchange fluoride f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (): 3 7 0 0 0 0 1
chemistry. Angew. chemistry. c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ...,..,,-. 10 7 0 0 0 0 1
(10) Narayanan, (10) ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,.. 8 8 0 0 0 0 1
warheads in warheads w wa war warh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ...,,-. 7 8 0 0 0 0 1
(11) Mortenson, (11) ( (1 (11 (11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,..;,.;,.;,.; 19 9 0 0 0 0 1
Li, S.; li, L Li Li, Li, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,.;,.;,..;,.;,..;,. 19 9 0 0 0 0 1
B.; Wilson, b.; B B. B.; B.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,.." 10 9 0 0 0 0 1
Identify Proteins identify I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 0 0 0 1
Exemplified by exemplified E Ex Exe Exem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 .....,,- 8 9 0 0 0 0 1
210. 210. 210. 2 21 210 210. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 . 1 0 0 0 0 0 1
(12) Brighty, (12) ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,..;,.;,.;,. 18 9 0 0 0 0 1
E.; Li, e.; E E. E.; E.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,.;,.;,.;,..;,. 17 8 0 0 0 0 1
B.; Kelly, b.; B B. B.; B.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,.. 5 8 0 0 0 0 1
sulfur(vi) fluoride sulfur(vi) s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ()... 5 9 0 0 0 0 1
2020, 12, 2020, 2 20 202 2020 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ,,-. 4 2 0 0 0 0 1
(13) Mukherjee, (13) ( (1 (13 (13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,.;,.;,.;, 15 9 0 0 0 0 1
B.; Dowling, b.; B B. B.; B.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,.;,.. 12 9 0 0 0 0 1
of S(VI)-F of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ()-- 4 8 0 0 0 0 1
chains under chains c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ....,, 6 9 0 0 0 0 1
9685-9695. 9685-9695. 9685-9695. 9 96 968 9685 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -. 2 1 0 0 0 0 1
(14) Gilbert, (14) ( (1 (14 (14) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,.;,.;,.;, 16 9 0 0 0 0 1
J.; Grant, j.; J J. J.; J.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,..;,.;,.;,. 18 10 0 0 0 0 1
A.; Bush, a.; A A. A.; A.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..() 7 7 0 0 0 0 1
Functionalities for functionalities F Fu Fun Func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 no 0 8 0 0 0 0 1
Ligandable Proteome. ligandable L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ...,,-. 7 7 0 0 0 0 1
(15) Oprea, (15) ( (1 (15 (15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,..;,.;,.;,. 18 9 0 0 0 0 1
N.; Gaulton, n.; N N. N.; N.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,.;,..;,.;,.;,.; 18 8 0 0 0 0 1
Jadhav, A.; jadhav, J Ja Jad Jadh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,.;,..;,..;,.;,..; 18 9 0 0 0 0 1
Ma'ayan, A.; ma'ayan, M Ma Ma' Ma'a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ',.;,.;,.;,..;,. 16 9 0 0 0 0 1
T.; Meehan, t.; T T. T.; T.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,.;,.;,..; 16 8 0 0 0 0 1
Overington, J. overington, O Ov Ove Over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,.;,.;,.;,..; 17 8 0 0 0 0 1
Schurer, S. schurer, S Sc Sch Schu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,.;,..;,.;,.; 17 9 0 0 0 0 1
Tudose, I.; tudose, T Tu Tud Tudo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,.;,.;,.;,.;,.;,. 17 9 0 0 0 0 1
J.; Zahoránszky-Köhalmi, j.; J J. J.; J.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;-,. 5 9 0 0 0 0 1
the human the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ...,,-. 7 8 0 0 0 0 1
(16) Parker, (16) ( (1 (16 (16) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,.;,.;,..;,.; 19 9 0 0 0 0 1
Joslyn, C. joslyn, J Jo Jos Josl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,..;,..;,..;, 17 9 0 0 0 0 1
S. R.; s. S S. S. S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ..;,.;,.;,.. 12 8 0 0 0 0 1
Discovery by discovery D Di Dis Disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 -., 3 8 0 0 0 0 1
168, 527-541.e29. 168, 1 16 168 168, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,-.. 4 2 0 0 0 0 1
(17) Zhao, (17) ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,.;,.;,..;,..; 19 8 0 0 0 0 1
Jones, L. jones, J Jo Jon Jone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,..;,.- 11 8 0 0 0 0 1
profiling in profiling p pr pro prof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 -.. 3 9 0 0 0 0 1
Am. Chem. am. A Am Am. Am. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ...,,-. 7 4 0 0 0 0 1
(18) Yang, (18) ( (1 (18 (18) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),.;,...;,.;,..; 17 9 0 0 0 0 1
Lenselink, E. lenselink, L Le Len Lens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,..;,.;,.. 14 8 0 0 0 0 1
Development of development D De Dev Deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 0 -: 2 8 0 0 0 0 1
A Case a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 8 0 ...., 5 8 0 0 0 0 1
62, 3539-3552. 62, 6 62 62, 62, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,-. 3 2 0 0 0 0 1
(19) Cruite, (19) ( (1 (19 (19) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 (),..;,..;,.;,..;,.; 20 9 0 0 0 0 1
Ficarro, S. ficarro, F Fi Fic Fica BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..;,..;,..;,.;,..;, 20 10 0 0 0 0 1
H.; Marto, h.; H H. H.; H.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .;,..;,..;,..;,..;,. 20 9 0 0 0 0 1
H. Cereblon h. H H. H. H. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 .- 2 8 0 0 0 0 1
histidine targeting histidine h hi his hist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 ...,,- 6 8 0 0 0 0 1
1110. 1110. 1110. 1 11 111 1110 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 . 1 0 0 0 0 0 1
(20) Carter, (20) ( (2 (20 (20) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,.;,.;-,.; 16 8 0 0 0 0 1
Arrowsmith, C. arrowsmith, A Ar Arr Arro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,..: 8 8 0 0 0 0 1
proteome. Drug proteome. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .,,-. 5 7 0 0 0 0 1
(21) Lu, (21) ( (2 (21 (21) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.;,.;,.;,..;, 19 9 0 0 0 0 1
L. H.; l. L L. L. L. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..;,..;,..- 11 9 0 0 0 0 1
discovery. RSC discovery. d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ...,,-. 7 6 0 0 0 0 1
(22) Keseru, (22) ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,.. 9 9 0 0 0 0 1
strategies on strategies s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ... 3 8 0 0 0 0 1
Discovery 2009, discovery D Di Dis Disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ,,-. 4 3 0 0 0 0 1
(23) Giordanetto, (23) ( (2 (23 (23) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.;,.;,.;,.. 17 9 0 0 0 0 1
Fragment Hits: fragment F Fr Fra Frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 :?. 3 8 0 0 0 0 1
Med. Chem. med. M Me Med Med. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..,,-. 6 4 0 0 0 0 1
(24) Pettinger, (24) ( (2 (24 (24) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.;,.;,.. 14 9 0 0 0 0 1
Optimization of optimization O Op Opt Opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 -.. 3 9 0 0 0 0 1
Med. Chem. med. M Me Med Med. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..,,-. 6 4 0 0 0 0 1
(25) Grant, (25) ( (2 (25 (25) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,..;,..;,...; 19 8 0 0 0 0 1
Quinn, C.; quinn, Q Qu Qui Quin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,..;,..;, 15 9 0 0 0 0 1
P.; Dixon, p.; P P. P.; P.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .;,..;,.;,.;,..;,.. 19 9 0 0 0 0 1
O.; Bush, o.; O O. O.; O.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .;,..-- 7 9 0 0 0 0 1
for Efficient for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ...,.. 6 9 0 0 0 0 1
2020, 59, 2020, 2 20 202 2020 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ,,-. 4 3 0 0 0 0 1
(26) Lanman, (26) ( (2 (26 (26) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,..;,..;,..; 18 9 0 0 0 0 1
Ashton, K. ashton, A As Ash Asht BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,..;,..;,.;,..; 19 9 0 0 0 0 1
Goodman, G.; goodman, G Go Goo Good BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,..;,.;,.;,..;,.; 20 9 0 0 0 0 1
Minatti, A. minatti, M Mi Min Mina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,..;,.;,..;,. 17 9 0 0 0 0 1
B.; Shin, b.; B B. B.; B.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 .;,.;,..;,..;,..;, 18 9 0 0 0 0 1
M. C.; m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ..;,..;,..;,.;,..;,.; 21 9 0 0 0 0 1
Bartberger, M. bartberger, B Ba Bar Bart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,.;,..;,..;,.; 18 9 0 0 0 0 1
Rex, K.; rex, R Re Rex Rex, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,..;,.;,..;,..; 18 9 0 0 0 0 1
Whittington, D. whittington, W Wh Whi Whit BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,..;,..;,.. 15 10 0 0 0 0 1
a Covalent a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 9 5 () 2 8 0 0 0 0 1
Solid Tumors. solid S So Sol Soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ....,,-. 8 6 0 0 0 0 1
(27) Shin, (27) ( (2 (27 (27) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,..;,..;,.;,.; 19 9 0 0 0 0 1
Bartberger, M. bartberger, B Ba Bar Bart BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,...;,.;,..; 16 9 0 0 0 0 1
Ingersoll, J.; ingersoll, I In Ing Inge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,..;,..;,.;,..; 18 9 0 0 0 0 1
McCarter, J.; mccarter, M Mc McC McCa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,.;,.;,..; 16 8 0 0 0 0 1
Sawayama, A.; sawayama, S Sa Saw Sawa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,..;,..;,.; 17 9 0 0 0 0 1
Lanman, B. lanman, L La Lan Lanm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,..;,..;,..-(- 14 8 0 0 0 0 1
Acryloylazetidin-3-yl)-2-(1 H-indol-1-yl)acetamides acryloylazetidin-3-yl)-2-(1 A Ac Acr Acry BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 --)--(---) 10 8 0 0 0 0 1
Inhibitors of inhibitors I In Inh Inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ....,,- 7 8 0 0 0 0 1
1308. 1308. 1308. 1 13 130 1308 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 . 1 0 0 0 0 0 1
(28) Green, (28) ( (2 (28 (28) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,.;,..;,.;, 17 9 0 0 0 0 1
A. J.; a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ..;,.-/ 7 9 0 0 0 0 1
hDM2 Protein-Protein hdm2 h hD hDM hDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 -....,,- 8 8 0 0 0 0 1
10689. 10689. 10689. 1 10 106 1068 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 . 1 0 0 0 0 0 1
(29) Thomas, (29) ( (2 (29 (29) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,..;,.;,..; 17 8 0 0 0 0 1
Pogány, P.; pogány, P Po Pog Pogá BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,..;,..;,.; 17 8 0 0 0 0 1
Tomkinson, N. tomkinson, T To Tom Tomk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,...;,..--- 11 9 0 0 0 0 1
chemistry approach chemistry c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ..., 4 9 0 0 0 0 1
12, 12098-12106. 12, 1 12 12, 12, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ,-. 3 2 0 0 0 0 1
(30) Rogers, (30) ( (3 (30 (30) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.-.. 10 8 0 0 0 0 1
Chem. Inf. chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ...,,-. 7 5 0 0 0 0 1
(31) Supuran, (31) ( (3 (31 (31) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..: 6 8 0 0 0 0 1
applications for applications a ap app appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 ... 3 9 0 0 0 0 1
2008, 7, 2008, 2 20 200 2008 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ,,-. 4 2 0 0 0 0 1
(32) Lomelino, (32) ( (3 (32 (32) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,..;,.- 13 8 0 0 0 0 1
inhibition of inhibition i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .....,,. 8 9 0 0 0 0 1
(33) Gokcen, (33) ( (3 (33 (33) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.;,.;,.. 14 8 0 0 0 0 1
sulfonamides as sulfonamides s su sul sulf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .. 2 9 0 0 0 0 1
Inhib. Med. inhib. I In Inh Inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ...,,-. 7 5 0 0 0 0 1
(34) Grant, (34) ( (3 (34 (34) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),..;,..;,..;,...; 19 9 0 0 0 0 1
Zappacosta, F.; zappacosta, Z Za Zap Zapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,...;,.. 14 9 0 0 0 0 1
Photoaffinity Displacement photoaffinity P Ph Pho Phot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
Dependent Kinase dependent D De Dep Depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ...,..,,- 9 8 0 0 0 0 1
17327. 17327. 17327. 1 17 173 1732 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 . 1 0 0 0 0 0 1
(35) Di (35) ( (3 (35 (35) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 (),.;,.;,.;,.;,.; 17 9 0 0 0 0 1
Wurl, M.; wurl, W Wu Wur Wurl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,..;,. 12 8 0 0 0 0 1
anhydrase inhibitors: anhydrase a an anh anhy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :- 2 9 0 0 0 0 1
complexed to complexed c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 no 0 9 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 10 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 10 11 ..,,- 5 8 0 1 0 0 0
1936 1936 1936 1 19 193 1936 BLOCKSTART PAGEEND NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 11 no 0 10 0 1 0 0 0
gln92 for gln92 g gl gln gln9 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -..... 6 9 0 0 0 0 1
2008, 18, 2008, 2 20 200 2008 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ,,-. 4 2 0 0 0 0 1
(36) Chen, (36) ( (3 (36 (36) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,..;,..; 19 9 0 0 0 0 1
Li, S.; li, L Li Li, Li, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,..;,..;,..; 21 9 0 0 0 0 1
Saez, E.; saez, S Sa Sae Saez BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,..;,..;,..;,.. 18 9 0 0 0 0 1
Arylfluorosulfates Inactivate arylfluorosulfates A Ar Ary Aryl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 () 2 9 0 0 0 0 1
through Chemoselective through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
Residue. J. residue. R Re Res Resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .....,,-. 9 6 0 0 0 0 1
(37) Fallon, (37) ( (3 (37 (37) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,.;,..;,.;, 17 9 0 0 0 0 1
C.; Fantom, c.; C C. C.; C.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,...;,.;,..;,.; 17 9 0 0 0 0 1
Schofield, C. schofield, S Sc Sch Scho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,...;,..- 13 9 0 0 0 0 1
of Photoaffinity of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --.. 4 8 0 0 0 0 1
Eur. J. eur. E Eu Eur Eur. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,,-. 6 4 0 0 0 0 1
(38) Li, (38) ( (3 (38 (38) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,./ 14 8 0 0 0 0 1
superfamily member, superfamily s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 , 1 8 0 0 0 0 1
cell lines. cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,,-. 8 6 0 0 0 0 1
(39) Wang, (39) ( (3 (39 (39) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;,.;,..;,. 18 9 0 0 0 0 1
A. A a. A A. A. A. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .:, 3 8 0 0 0 0 1
distribution and distribution d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,. 5 9 0 0 0 0 1
Cell Biol. cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .,,-. 5 5 0 0 0 0 1
(40) Hengst, (40) ( (4 (40 (40) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,. 13 7 0 0 0 0 1
phosphatidylethanolamine-binding protein phosphatidylethanolamine-binding p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
novel family novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,, 6 9 0 0 0 0 1
535-540. 535-540. 535-540. 5 53 535 535- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 1 0 0 0 0 1
(41) Kerres, (41) ( (4 (41 (41) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,.;,.;,.;,.; 17 9 0 0 0 0 1
Caligiuri, M.; caligiuri, C Ca Cal Cali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,.;,.; 16 9 0 0 0 0 1
Flotzinger, G.; flotzinger, F Fl Flo Flot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.;,.; 15 9 0 0 0 0 1
Han, B.; han, H Ha Han Han, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,.;,.;,.; 19 9 0 0 0 0 1
Lancia, D. lancia, L La Lan Lanc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,.;,.;,.;,.;, 17 9 0 0 0 0 1
K.; Peinsipp, k.; K K. K.; K.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,.;,.;,.;,.;,.; 17 9 0 0 0 0 1
Salomon, C.; salomon, S Sa Sal Salo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.;,.; 15 9 0 0 0 0 1
Thompson, D.; thompson, T Th Tho Thom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.;-,.; 16 9 0 0 0 0 1
Winkler, S.; winkler, W Wi Win Wink BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.;,.; 15 8 0 0 0 0 1
Pearson, M.; pearson, P Pe Pea Pear BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,. 5 8 0 0 0 0 1
Oncogenic Transcription oncogenic O On Onc Onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..,,- 5 8 0 0 0 0 1
2875. 2875. 2875. 2 28 287 2875 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 . 1 0 0 0 0 0 1
(42) Pearce, (42) ( (4 (42 (42) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..;,.;,.;, 17 9 0 0 0 0 1
M. A.; m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ..;,.;,.;,.;,..;,. 18 9 0 0 0 0 1
S.; Hutchinson, s.; S S. S.; S.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,..;,.;,.;,..;, 17 9 0 0 0 0 1
C.; Morley, c.; C C. C.; C.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,.;,..;-,.;,..; 17 8 0 0 0 0 1
Schofield, J.; schofield, S Sc Sch Scho BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,..;,.; 16 8 0 0 0 0 1
Zhang, X. zhang, Z Zh Zha Zhan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,..,- 9 8 0 0 0 0 1
inhibitor with inhibitor i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,. 2 9 0 0 0 0 1
J. Biol. j. J J. J. J. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,,. 6 4 0 0 0 0 1
(43) McCoull, (43) ( (4 (43 (43) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;,.;,.;, 16 9 0 0 0 0 1
P.; Box, p.; P P. P.; P.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,.;,.;,.;,.;,.;,..; 21 10 0 0 0 0 1
Cheung, T.; cheung, C Ch Che Cheu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,.;,..; 17 9 0 0 0 0 1
Gangl, E.; gangl, G Ga Gan Gang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,.;,.;,..;,.; 19 9 0 0 0 0 1
Kemmitt, P. kemmitt, K Ke Kem Kemm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,..;',.;,..;,.; 19 9 0 0 0 0 1
Rawlins, P. rawlins, R Ra Raw Rawl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,..;,.;,..;,.; 18 9 0 0 0 0 1
Wylot, M.; wylot, W Wy Wyl Wylo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.[,-]- 10 8 0 0 0 0 1
Lymphoma 6 lymphoma L Ly Lym Lymp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 () 2 8 0 0 0 0 1
Macrocyclic Inhibitors. macrocyclic M Ma Mac Macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,,-. 8 7 0 0 0 0 1
(44) Teng, (44) ( (4 (44 (44) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;,.;,.;,.;,. 20 9 0 0 0 0 1
S.; Marto, s.; S S. S.; S.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .;,..;,.;,.. 12 9 0 0 0 0 1
BCL6 Inhibitor bcl6 B BC BCL BCL6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
Interface. ACS interface. I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ....,,-. 8 7 0 0 0 0 1
(45) Vedadi, (45) ( (4 (45 (45) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;-,.;,..; 17 9 0 0 0 0 1
Finerty, P. finerty, F Fi Fin Fine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,..;,..;,.;,.;,..; 18 9 0 0 0 0 1
Berglund, H.; berglund, B Be Ber Berg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..;,.;,.; 16 9 0 0 0 0 1
Weigelt, J.; weigelt, W We Wei Weig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.. 6 9 0 0 0 0 1
ligands that ligands l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 ,, 2 9 0 0 0 0 1
structure determination. structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ........,, 10 8 0 0 0 0 1
15835-15840. 15835-15840. 15835-15840. 1 15 158 1583 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 -. 2 1 0 0 0 0 1
(46) Boike, (46) ( (4 (46 (46) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),.;,..;,.. 12 9 0 0 0 0 1
drug discovery. drug d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ...,,-. 7 8 0 0 0 0 1
(47) Jones, (47) ( (4 (47 (47) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (),..;,..- 10 9 0 0 0 0 1
SuFEx chemical sufex S Su SuF SuFE BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ...,,-. 7 7 0 0 0 0 1
(48) Gambini, (48) ( (4 (48 (48) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 (),.;,.;,.;,.;,. 16 9 0 0 0 0 1
F.; Perry, f.; F F. F.; F.; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 .;,...;,.- 10 10 0 0 0 0 1
Interactions Targeting interactions I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,,... 5 9 0 0 0 0 1
Chem. 2019, chem. C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 .,,-. 5 3 0 0 0 0 1
(49) Che, (49) ( (4 (49 (49) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 (),.;,..- 9 8 0 0 0 0 1
unexploited opportunity? unexploited u un une unex BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 10 ?..,,-. 7 8 0 0 0 0 1
ACS Chemical acs A AC ACS ACS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology pubs.acs.org/acschemicalbiology p pu pub pubs BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 ../ 3 10 0 1 0 0 0
Articles Articles articles A Ar Art Arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 2 0 1 0 0 0
https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 https://doi.org/10.1021/acschembio.3c00034 h ht htt http BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 11 ://././. 8 10 0 1 0 0 0
ACS Chem. acs A AC ACS ACS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 ..,,- 5 8 0 1 0 0 0
1937 1937 1937 1 19 193 1937 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 11 no 0 10 0 1 0 0 0

